RebrAIn

RebrAIn is a private France-based precision neurosurgery and healthtech company developing AI-guided software to support targeting for deep brain stimulation and lesioning procedures. The company is a spin-off from Bordeaux University Hospital and Inria and commercializes Software as a Medical Device products including OptimMRI and OptimDBS. Its technology uses supervised machine learning applied to MRI-based planning to help neurosurgeons identify patient-specific targets such as the subthalamic nucleus and ventral intermediate nucleus. RebrAIn focuses on movement disorder procedures in Parkinson's disease and essential tremor, and its software has obtained CE mark/FDA 510(k) clearances, with MDR certification for OptimMRI in Europe. The company operates in Europe and the United States and is expanding adoption with leading neurosurgery centers.